Hims & Hers grants director Huberman two stock awards

Available on EDGAR 11/13/2026 - 04:17 PM EST Accepted by SEC EDGAR 11/13/2026 - 04:17 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) director Andrew D. Huberman received two direct restricted stock unit awards on November 11, 2026: 14,020 RSUs and 5,281 RSUs. Each RSU represents a contingent right to one share of Class A Common Stock.

The 14,020-RSU award vests in three substantially equal installments, subject to continuous service, at the first quarterly vesting date after each of the first, second and third anniversaries of the director’s service commencement. The 5,281-RSU award vests in full, also subject to continuous service, at the first quarterly vesting date after the earlier of the company’s next annual stockholder meeting or the award’s first anniversary.

Insider Trade Summary

Grant/Award: 19,301 shares

Grant/Award 2 txns

Insider Huberman Andrew D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit F1, F2	14,020	$0.00	$0.00
Grant/Award	Restricted Stock Unit F1, F3	5,281	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 19,301 units (Direct)

Holdings Before and After: Restricted Stock Unit, 0 to 19,301 units (Direct)

Footnotes (3)

1. F1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
2. F2. Subject to continuous service, the RSUs under the award will vest in three substantially equal installments, with one-third of the RSUs vesting on the first Company quarterly vesting date to occur after each of the first, second, and third anniversaries of the director's service commencement date.
3. F3. Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award.

Key Figures

Restricted stock units awarded: 14,020 RSUs Restricted stock units awarded: 5,281 RSUs

2 metrics

Restricted stock units awarded 14,020 RSUs Direct award to director Andrew D. Huberman on November 11, 2026

Restricted stock units awarded 5,281 RSUs Direct award to director Andrew D. Huberman on November 11, 2026

Key Terms

Restricted Stock Units, quarterly vesting date

2 terms

Restricted Stock Units technical

"The Restricted Stock Units ("RSUs") represent a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

quarterly vesting date technical

"the first Company quarterly vesting date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What RSU awards did HIMS director Andrew D. Huberman receive?

Andrew D. Huberman received 14,020 RSUs and 5,281 RSUs on November 11, 2026. Each RSU represents a contingent right to receive one share of Class A Common Stock.

How do Andrew D. Huberman’s HIMS RSU awards vest?

The 14,020-RSU award vests in three substantially equal installments, subject to continuous service, after the first, second and third anniversaries of his service commencement. The 5,281-RSU award vests in full, subject to continuous service, after the earlier of the company’s next annual stockholder meeting or the award’s first anniversary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Huberman Andrew D

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	11/11/2026		A		14,020		(2)	(2)	Class A Common Stock	14,020	$0	14,020	D
Restricted Stock Unit	(1)	11/11/2026		A		5,281		(3)	(3)	Class A Common Stock	5,281	$0	5,281	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. Subject to continuous service, the RSUs under the award will vest in three substantially equal installments, with one-third of the RSUs vesting on the first Company quarterly vesting date to occur after each of the first, second, and third anniversaries of the director's service commencement date.

3. Subject to continuous service, the RSUs will vest in full on the first Company quarterly vesting date to occur after the earlier of (x) the date of the Company's next-occurring annual stockholder meeting or (y) the first anniversary of the grant date of the award.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Andrew D Huberman	11/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)